Greg Korbel

Greg Korbel

Company: Aprea Therapeutics

Job title: Chief Operating Officer


Adding On to Monotherapy: Combining DDR Inhibitors 2:00 pm

Combinations to combat emerging resistance; identifying combination agents Can the combination of DDRis result in overlapping toxicity? A case study of combining PARPi and ATRi Circumventing PLK inhibition: combining ATRN-W1051 with Wee1 or ATR inhibitorsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.